TY  - GEN
AU  - Cohen,S
AU  - Levy,R M
AU  - Keller,M
AU  - Boling,E
AU  - Emkey,R D
AU  - Greenwald,M
AU  - Zizic,T M
AU  - Wallach,S
AU  - Sewell,K L
AU  - Lukert,B P
AU  - Axelrod,D W
AU  - Chines,A A
TI  - Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
SN  - 0004-3591
PY  - 1999///1122
KW  - Adolescent
KW  - Adrenal Cortex Hormones
KW  - adverse effects
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Analysis of Variance
KW  - Biomarkers
KW  - Bone Resorption
KW  - chemically induced
KW  - Calcium Channel Blockers
KW  - Demography
KW  - Double-Blind Method
KW  - Etidronic Acid
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Risedronic Acid
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K
ER  -